Showing results (541-550 of 1,078) with videos related to
Sort By:
Pageof 108
Annals of Surgical Oncology|July 24, 2015
Prevalence and Clinicopathological Characteristics of BRAF Mutations in Chinese Patients with Lung AdenocarcinomaDifan Zheng, Rui Wang, Yunjian Pan, et al.JAMA Surgery|February 5, 2015
Comparison of Ivor-Lewis vs Sweet esophagectomy for esophageal squamous cell carcinoma: a randomized clinical trialBin Li, Jiaqing Xiang, Yawei Zhang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 20, 2019
Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical SubtypeTing Ye, Lin Deng, Shengping Wang, et al.Journal of Cancer Research and Clinical Oncology|December 12, 2018
Preoperative brain MRI for clinical stage IA lung cancer: is routine scanning rational?Lingdun Zhuge, Yangle Huang, Shengfei Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2012
The use of quantitative real-time reverse transcriptase PCR for 5' and 3' portions of ALK transcripts to detect ALK rearrangements in lung cancersRui Wang, Yunjian Pan, Chenguang Li, et al.Journal of Cancer Research and Clinical Oncology|October 14, 2017
Are exon 19 deletions and L858R different in early stage lung adenocarcinoma?Yiliang Zhang, Yuan Ma, Yuan Li, et al.Journal of Thoracic Disease|March 13, 2023
Neoadjuvant therapy with immunoagent (nivolumab) or placebo plus chemotherapy followed by surgery and adjuvant treatment in subjects with resectable esophageal squamous cell carcinoma: study protocol of a randomized, multicenter, double blind, phase II trial (NATION-2203 trial)Jun Yin, Siyun Lin, Yong Fang, et al.Lung Cancer (Amsterdam, Netherlands)|March 18, 2014
ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic featuresYunjian Pan, Yang Zhang, Yuan Li, et al.Annals of Surgical Oncology|January 15, 2014
Prevalence, clinicopathologic characteristics, and molecular associations of EGFR exon 20 insertion mutations in East Asian patients with lung adenocarcinomaYunjian Pan, Yang Zhang, Yuan Li, et al.Cell Research|January 25, 2014
VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complexWenjing Zhang, Yijun Gao, Peixue Li, et al.Pageof 108